Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions

Pigment Cell and Melanoma Research

Volumn 26, Issue 1, 2013, Pages 144-146

  Maldi, Elena ^a   Travelli, Cristina ^a   Caldarelli, Antonio ^a   Agazzone, Nicolò ^a   Cintura, Sara ^a   Galli, Ubaldina ^a   Scatolini, Maria ^b   Ostano, Paola ^b   Miglino, Benedetta ^a   Chiorino, Giovanna ^b   Boldorini, Renzo ^a   Genazzani, Armando A ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Laboratory of Cancer Genomics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; DAPORINAD; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TEMOZOLOMIDE;

DRUG EFFECT; DYSPLASTIC NEVUS; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LETTER; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; MELANOMA CELL; MELANOMA METASTASIS; NEUROBLASTOMA CELL; PROTEIN EXPRESSION;

ACRYLAMIDES; CELL DEATH; CELL LINE, TUMOR; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PIPERIDINES; SKIN NEOPLASMS;

EID: 84871462964     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12037     Document Type: Letter

References (7)

1. Colombano, G., Travelli, C., Galli, U., Caldarelli, A., Chini, M.G., Canonico, P.L., Sorba, G., Bifulco, G., Tron, G.C., and Genazzani, A. (2009). A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry. J. Med. Chem. 53, 616-623.
2. Imai, S. (2009). Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr. Pharm. Des. 15, 20-28.
3. Pittelli, M., Formentini, L., Faraco, G., Lapucci, A., Rapizzi, E., Cialdai, F., Romano, G., Moneti, G., Moroni, F., and Chiarugi, A. (2010). Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J. Biol. Chem. 285, 34106-34114.
4. Reddy, P.S., Umesh, S., Thota, B. et al. (2008). PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value. Cancer Biol. Ther. 7, 663-668.
5. Travelli, C., Drago, V., Maldi, E., Kaludercic, N., Galli, U., Boldorini, R.L., Di lisa, F., Tron, G.C., Canonico, P.L., and Genazzani, A.A. (2011). Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells. J. Pharmacol. Exp. Ther. 338, 829-840.
6. Wachsman, W., Morhenn, V., Palmer, T. et al. (2011). Noninvasive genomic detection of melanoma. Br. J. Dermatol. 164, 797-806.
7. Wang, B., Hasan, M.K., Alvarado, E., Yuan, H., Wu, H., and Chen, W.Y. (2011). NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene 30, 907-921.